Biocon Ltd. — Regulatory Filings 2020

Nov 17, 2020

==> picture [88 x 35] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

November 17, 2020

To To The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 050 Scrip Code - 532523 Scrip Symbol - BIOCON Dear Sir/Madam,

Sub: Meeting conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meeting was conducted with Institutional Investor / Research Analysts:

Date	Name	Type of meeting	Location
November 16, 2020	Multiple investors	Fireside Chat - part ofa Plenary Session ofVirtual Conference	Bengaluru
November 17, 2020	Allianz Global Investors Asia Pacific Ltd	1x1&GroupMeetings - Virtual	Bengaluru
	Champlain Investment Partners LLC
	Cooper Investors PtyLtd
	FidelityInvestments
	ICICI Prudential Life Insurance Co. Ltd.
	Lion Global Investors Ltd
	Maybank Asset Management SingaporePte. Ltd
	MFS Investment Management
	Nikko Asset Management Asia Ltd.
	OMERS
	PAG Capital - HongKong
	Tree Line Advisors(Singapore)Pte Ltd
	Tudor Investment Corp
	Wellington Management LLP

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [76 x 32] intentionally omitted <==

==> picture [70 x 74] intentionally omitted <==

---

Mayank Verma

Company Secretary and Compliance Officer